Please assess the completion status of the following clinical trial:

Trial Title: MRS and Medication Response: A Pilot Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Major depressive disorder:~Inclusion Criteria:~1. DSM diagnosis of Major Depressive Disorder~2. Taking paroxetine \[(Paxil) or citalopram (Celexa) or escitalopram (Lexapro)\]for at least 6 weeks~3. Between 21 - 75 years of age.~4. Taking a stable dose of paroxetine \[(Paxil) or citalopram (Celexa) or escitalopram (Lexapro)\] for at least the 2 weeks prior to the imaging session~Healthy controls:~1. Between 21 - 75 years of age.~2. Have a 21-item HAM-D score of less than or equal to 5.~3. No current, or history of any Axis I disorder.~Identify exclusion criteria.~Exclusion criteria are as follows:~1. Contraindications for an MRI exam. These includes biomedical devices such as pacemakers, aneurysm clips, prostheses, and other metallic objects embedded in the body such as bullets, buckshot, shrapnel, and any metal fragments from working around metal.~2. Current pregnancy or lactation.~3. Patients with claustrophobia.~4. History, or current Axis I or Axis II disorders~5. Active unstable medical problems, as confirmed by screening procedures~6. Diagnosed with any autoimmune disease, (e.g., rheumatoid arthritis, Lupus, MLS).~7. Chronic use of steroids or opiates.~8. Positive urine toxicology screen for illicit substances of abuse.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Major depressive disorder (Type: None): There is no intervention/treatment in this study.
- Non-depressed individuals (Type: None): There is no intervention/treatment in this study.

Based on this trial design, predict the completion outcome and termination type (if applicable).